Achaogen (AKAO) Misses Q3 EPS by 22c

Achaogen (NASDAQ: AKAO) reported Q3 EPS of ($0.47), $0.22 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $4.52 million versus the consensus estimate of $6 million.

For earnings history and earnings-related data on Achaogen (AKAO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Vivos Therapeutics posts 35% revenue gain but widens net loss